Report ID: UCMIG35I2215
Report ID:
UCMIG35I2215 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
The worldwide canine atopic dermatitis market had an approximate value of USD 911.6 million in 2019, with a projected Compound Annual Growth Rate (CAGR) of 9.0% expected over the forecast period. Canine atopic dermatitis, a common skin condition affecting dogs, has seen significant growth in its market size due to the rising prevalence of the disease and increasing awareness among pet owners about its management and treatment. Factors such as the growing pet adoption rates, advancements in veterinary dermatology research, and the introduction of innovative therapies have contributed to the market's expansion. As a result, the market for canine atopic dermatitis is anticipated to witness sustained growth in the coming years.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Canine Atopic Dermatitis was estimated to be valued at US$ XX Mn in 2021.
The Canine Atopic Dermatitis Market is estimated to grow at a CAGR of XX% by 2028.
The Canine Atopic Dermatitis Market is segmented on the basis of Product, Mode of Administration, Distribution Channel, Regional.
Based on region, the Canine Atopic Dermatitis Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Canine Atopic Dermatitis Market are Zoetis Inc., Elanco Animal Health Inc., Virbac, Boehringer Ingelheim Animal Health, Bayer AG, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Kindred Biosciences, Inc., Aratana Therapeutics, Inc..
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35I2215